Amphastar Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	719.89	731.97	644.4	498.99	437.77
Revenue Growth (YoY)	-1.65%	13.59%	29.14%	13.98%	25.13%
Cost of Revenue	363.83	358.11	293.27	250.13	238.03
Gross Profit	356.06	373.86	351.12	248.86	199.74
Selling, General & Admin	129.81	94.52	80.39	66.59	68.92
Research & Development	85.84	73.91	73.74	74.77	60.93
Total Operating Expenses	215.65	168.44	154.13	141.36	129.85
Operating Income	140.4	205.42	196.99	107.5	69.89
Interest Income	8.68	10.61	5.46	1.32	0.6
Interest Expense	-25.48	-30.34	-27.16	-1.85	-0.89
Other Non-Operating Income (Expense)	0.02	4.08	-3.93	9.07	14.54
Total Non-Operating Income (Expense)	-16.78	-15.66	-25.63	8.54	14.25
Pretax Income	123.62	189.76	171.36	116.04	84.14
Provision for Income Taxes	25.53	29.67	31.83	23.48	20.63
Net Income	98.09	159.52	137.55	91.39	64.49
Minority Interest in Earnings	-	0.57	1.98	1.18	-0.98
Net Income to Common	98.09	159.52	137.55	91.39	64.49
Net Income Growth	-38.51%	15.98%	50.51%	41.71%	8052.46%
Shares Outstanding (Basic)	47	48	48	49	48
Shares Outstanding (Diluted)	48	52	53	52	50
Shares Change (YoY)	-7.38%	-1.78%	1.09%	5.31%	1.34%
EPS (Basic)	2.10	3.29	2.85	1.88	1.30
EPS (Diluted)	2.03	3.06	2.60	1.74	1.25
EPS Growth	-33.66%	17.69%	49.43%	39.20%	4066.67%
Free Cash Flow	121.23	172.35	145.34	65.15	70.54
Free Cash Flow Growth	-29.66%	18.58%	123.09%	-7.64%	201.30%
Free Cash Flow Per Share	2.51	3.31	2.74	1.24	1.42
Gross Margin	49.46%	51.08%	54.49%	49.87%	45.63%
Operating Margin	19.50%	28.06%	30.57%	21.54%	15.96%
Profit Margin	13.63%	21.87%	21.65%	18.55%	14.51%
FCF Margin	16.84%	23.55%	22.55%	13.06%	16.11%
EBITDA	197.1	258.39	235.02	132.27	93.15
EBITDA Margin	27.38%	35.30%	36.47%	26.51%	21.28%
EBIT	140.4	205.42	196.99	107.5	69.89
EBIT Margin	19.50%	28.06%	30.57%	21.54%	15.96%
Effective Tax Rate	20.65%	15.64%	18.58%	20.23%	24.52%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q